Concepedia

Chiara Tarantelli

CT

34

Publications

1.4K

Citations

20

H-Index

2011

Active since

Affiliations

Institute of Oncology Research(Current)

Università della Svizzera italiana

SIB Swiss Institute of Bioinformatics

University of Turin

Dalle Molle Institute for Artificial Intelligence Research

Chiara Tarantelli is an author at Institute of Oncology Research specializing in medicine, pharmacology, and tumor biology.

ORCID

Top concepts

Publications per year

2011–2024

34

Publications

34

The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs

Michela Boi, Eugenio Gaudio, Paola Bonetti et al. · Clinical Cancer Research · 2015 · 281 citations

PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy

Chiara Tarantelli, Eugenio Gaudio, Alberto J. Arribas et al. · Clinical Cancer Research · 2017 · 117 citations

Biological and clinical implications of <i>BIRC3</i> mutations in chronic lymphocytic leukemia

Fary Diop, Riccardo Moia, Chiara Favini et al. · Haematologica · 2019 · 82 citations · Full text

Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734

Filippo Spriano, Eugenio Gaudio, Luciano Cascione et al. · Blood Advances · 2020 · 70 citations · Full text

The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents

Filippo Spriano, Elaine Y. Chung, Eugenio Gaudio et al. · Clinical Cancer Research · 2019 · 67 citations

Rows per page

1–5 of 34